Extensions

For US Patent 11,623,920, here's a detailed breakdown of its term and related applications:

Patent Term Adjustment (PTA)

Patent Term Adjustment (PTA) compensates for certain administrative delays by the USPTO during patent prosecution, adding days to the patent's 20-year term from its earliest filing date. While the specific PTA amount for US 11,623,920 is not directly stated in the provided text, the USPTO automatically determines and provides this information by the patent's issue date. Applicants have a window to request reconsideration of the PTA determination.

Patent Term Extension (PTE)

Patent Term Extension (PTE) is granted to compensate patent owners for delays incurred in obtaining regulatory approval for certain products, primarily pharmaceuticals, from agencies like the FDA. The provided patent text does not indicate if US 11,623,920 has received or is eligible for PTE. Typically, PTE applies to one patent per regulatory review period and is limited to a maximum of five years, with the total patent life not exceeding 14 years from FDA approval.

Continuation Applications

The patent text explicitly states a priority claim to US 18/174,238, filed on February 24, 2023. This indicates that US 18/174,238 is a related application, and given the later filing date relative to the priority applications (Indian Patent Application Nos. 202141025328, 202141035609, 202141046743, and 202241009416), it could potentially be a continuation, divisional, or continuation-in-part of another application in the family, or a new application claiming priority from the Indian applications. However, the exact type of relationship (e.g., continuation, divisional) to this specific US patent 11623920 is not definitively stated in the provided text beyond being a priority claim.

Divisional Applications

The provided patent text does not explicitly mention any divisional applications directly stemming from US 11,623,920.

Related Family Members

The patent claims priority to the following Indian Patent Application Nos.:

• 202141025328, filed on June 7, 2021
• 202141035609, filed on August 6, 2021
• 202141046743, filed on October 13, 2021
• 202241009416, filed on February 22, 2022

Additionally, a priority claim is made to US 18/174,238, filed on February 24, 2023. These constitute the related family members for this patent.

Projected Expiration Date

The anticipated expiration date for US Patent 11,623,920 is May 24, 2042. This date is typically calculated as 20 years from the earliest filing date of the application, subject to any Patent Term Adjustments (PTA) or extensions. The filing date of the application that led to US 11,623,920 was May 24, 2022.